Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin degludec versus insulin glargine for glucose variability in adults with type 1 diabetes in northern China
ChiCTR2000032703Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Harbin Medical University
- Start
- May 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of insulin degludec and insulin glargine in diabetes mellitus type 1 (T1D) (2 arms), sponsored by The First Affiliated Hospital of Harbin Medical University. Primary endpoints: 24-hour mean glucose level, Standard deviation of 24-hour glucose levels and 9 more. Started May 2020; status: recruiting.
02
Drugs
insulin degludecinsulin glargine
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on ChiCTR2000032703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032703.